These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Comparative study of the effect of quinacrine, nivaquine B and C on giardiasis]. COUTELEN F; BRETON A; BIGUET J; DEBLOCK S; MULLET S; DOBY JM Bull Soc Pathol Exot Filiales; 1955; 48(3):429-37. PubMed ID: 13304623 [No Abstract] [Full Text] [Related]
25. Naxogen (nitrimidazine) in giardiasis. Pai VR; Wadia FF; Dange M; Sule CR; Kale SS J Assoc Physicians India; 1974 Jul; 22(7):531-3. PubMed ID: 4436244 [No Abstract] [Full Text] [Related]
26. [Symposium on the use of flaguil in amoebiasis and lambliasis. (Literature review)]. Gordeeva LM Med Parazitol (Mosk); 1969; 38(5):606-8. PubMed ID: 4906159 [No Abstract] [Full Text] [Related]
27. Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs. Meyer EK J Am Vet Med Assoc; 1998 Jul; 213(1):44-6. PubMed ID: 9656022 [No Abstract] [Full Text] [Related]
28. Secnidazole response in amoebiasis and giardiasis. Qureshi H; Baqai R; Mehdi I; Ahmed W East Mediterr Health J; 1999 Mar; 5(2):389-90. PubMed ID: 10793818 [No Abstract] [Full Text] [Related]
29. The treatment of giardiasis with albendazole. Di Rosa S; Affronti M; Malta R; Scardavi M; Vassallo L; Occhino C; Maggio A; Savalli F; Rini GB J Chemother; 1989 Jul; 1(4 Suppl):948. PubMed ID: 16312717 [No Abstract] [Full Text] [Related]
30. [Various diagnostic and therapeutic problems of lambliasis in children]. Kopeć B; Hanuszkiewicz M Pediatr Pol; 1983 Apr; 58(4):331-6. PubMed ID: 6634248 [No Abstract] [Full Text] [Related]
31. [Experimental study of a new anti-lambliasis preparation Chlodophen--bis(2,4-dichlorophenyliodonium) chloride]. Pershin GN; Novitskaia NA; Milovanova SN; Zykova TN Med Parazitol (Mosk); 1971; 40(1):78-81. PubMed ID: 5087694 [No Abstract] [Full Text] [Related]
32. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis. Taylor GD; Wenman WM; Tyrrell DL CMAJ; 1987 Jun; 136(11):1179-80. PubMed ID: 3567779 [No Abstract] [Full Text] [Related]
33. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. Mørch K; Hanevik K; Robertson LJ; Strand EA; Langeland N J Infect; 2008 Apr; 56(4):268-73. PubMed ID: 18328567 [TBL] [Abstract][Full Text] [Related]
34. [Human lambliasis and its therapy]. Prezioso M Friuli Med; 1967; 22(4):1019-28. PubMed ID: 5596241 [No Abstract] [Full Text] [Related]
35. [Clinical forms of lambliasis in small children]. Burdzińska-Golowin J; Lewandowska J; Misiukowa G Pediatr Pol; 1967 Jun; 42(6):685-91. PubMed ID: 6061119 [No Abstract] [Full Text] [Related]
36. Efficacy of various drugs in treatment of giardiasis: comparative study. Levi GC; de Avila CA; Neto VA Rev Inst Med Trop Sao Paulo; 1977; 19(6):422-4. PubMed ID: 613436 [No Abstract] [Full Text] [Related]
38. Synergistic role of intestinal flagellates and normal intestinal bacteria in a post-weaning mortality of mice. Boorman GA; van Hooft JI; van der Waaij D; van Noord MJ Lab Anim Sci; 1973 Apr; 23(2):187-93. PubMed ID: 4349878 [No Abstract] [Full Text] [Related]
39. [Comparative evaluation of efficacy of treating giardiasis with drug- or phytotherapy]. Shakarov AG; Vakhabov TA; Nabieva GP Med Parazitol (Mosk); 2003; (1):21-3. PubMed ID: 12652841 [No Abstract] [Full Text] [Related]